PRESS RELEASE published on 01/02/2024 at 18:00, 1 year 11 months ago Cloud9 Esports Welcomes Tim Mulligan as New Head of Sales Premier North American esports organization, Cloud9, has appointed Tim Mulligan as the new VP, Head of Sales. With over 25 years of experience in the gaming industry, Mulligan brings expertise in Sales, Marketing, and Public Relations to the Cloud9 team. His role will focus on revenue generation, sponsor relationship management, strategic planning, and brand representation, driving Cloud9's continued growth and success. Cloud9 Tim Mulligan Esports Organization Sales Strategic Partnerships
PRESS RELEASE published on 12/05/2023 at 20:00, 1 year 11 months ago Cloud9 and Toei Animation Join Forces to Release a New 'One Piece' Apparel Collection Cloud9 and Toei Animation collaborate to launch Cloud9 x One Piece, a new apparel collection inspired by the iconic 'One Piece' anime series. The collection includes trendy and comfortable clothing pieces for esports enthusiasts and anime fans Esports Cloud9 X One Piece Apparel Collection Toei Animation Anime Series
Published on 12/05/2025 at 02:35, 3 hours 20 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 55 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 50 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 55 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 25 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 4 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 30 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 40 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 45 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 55 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 10 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 11 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 54 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025